SCHEMBL9874150

SCHEMBL9874150

COc1nnc(OC)c2c1nc(C(C)C)n2Cc1ccc(-c2ccccc2C(=O)O)cc1

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PPARG P37231 5/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9874913 0.94 PPARG (0.46) PPARG
SCHEMBL9874461 0.90 AGTR1 (0.45) PPARG
SCHEMBL9879537 0.90 PPARG (0.46) PPARG
SCHEMBL9873500 0.90 AGTR1 (0.47) PPARG
SCHEMBL9874863 0.89 AGTR1 (0.45) PPARG
SCHEMBL9874758 0.89 AGTR1 (0.48) PPARG
SCHEMBL9873268 0.89 PPARG (0.45) PPARG
SCHEMBL9874291 0.87 PPARG (0.52) PPARG
SCHEMBL9873708 0.87 PPARG (0.44) PPARG
SCHEMBL9873885 0.86 PPARG (0.42) PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991019715-A1 1H-SUBSTITUTED-IMIDAZO[4,5-d]PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-12-26 WO disclosed